(Applicant's description) This Comprehensive Cancer Center is based at the University of Alabama at Birmingham (UAB) and the UAB Medical Center. The Center has been funded by NCI continuously since 1971 and currently has 228 faculty members, $49.3 million of research support, and 138,000 square feet of Cancer Center controlled space. The Cancer Center administratively functions as a matrix organization with involvement of faculty and resources from 36 departments in seven Schools of the institution. The Center evaluates 3,000 new cancer cases annually and places about 700 patients on clinical trials. The Center has 100 cancer beds in the University of Alabama Hospital and extensive modern ambulatory facilities in The Kirklin Clinic. It has a strong emphasis on interdisciplinary and translational research efforts. It is organized into seven major program areas: Immunology, Structured Biology, Molecular Genetics, Virology, Experimental Therapeutics, Neuro-Oncology, and Cancer Prevention and Control. It has a developmental program in Breast/Ovary/ Prostate cancer. The Center supports 12 shared facilities including Biostatistics, Clinical Studies, Tissue Procurement, Cell Marker/In Situ Hybridization, Electron Microscopy, Fermentation, Mass Spectroscopy, Media Preparation, Oligonucleotide Synthesis, Peptide Synthesis and Analysis, Nuclear Magnetic Resonance, and X-ray Crystallography. This proposal also requests shared facility support for a Transgenic Animal. Pathogen Free Rodent, Radiolabeling, Protein Purification and Micro-Analysis, and Clinical Molecular Biology facility. In addition, the Center has an active developmental effort with annual pilot research project funding and funding for support of new investigator recruitment and/or start-up. A formal planning process involving internal committees and external consultants provides advice to the senior leadership of the Center. The Center has strong support from the university and a productive record of successful competitive grant support and scientific publications.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA013148-28S3
Application #
6156142
Study Section
Cancer Center Support Review Committee (CCS)
Program Officer
Silkensen, Shannon M
Project Start
1985-07-01
Project End
2000-02-29
Budget Start
1999-03-12
Budget End
2000-02-29
Support Year
28
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Leath 3rd, Charles A; Monk, Bradley J (2018) Twenty-first century cervical cancer management: A historical perspective of the gynecologic oncology group/NRG oncology over the past twenty years. Gynecol Oncol 150:391-397
Park, Misun; Yoon, Young Sup (2018) Cardiac Regeneration with Human Pluripotent Stem Cell-Derived Cardiomyocytes. Korean Circ J 48:974-988
Toboni, Michael D; Smith, Haller J; Bae, Sejong et al. (2018) Predictors of Unplanned Reoperation for Ovarian Cancer Patients From the National Surgical Quality Improvement Program Database. Int J Gynecol Cancer 28:1427-1431
Dionne-Odom, J Nicholas; Applebaum, Allison J; Ornstein, Katherine A et al. (2018) Participation and interest in support services among family caregivers of older adults with cancer. Psychooncology 27:969-976
Demark-Wahnefried, Wendy; Schmitz, Kathryn H; Alfano, Catherine M et al. (2018) Weight management and physical activity throughout the cancer care continuum. CA Cancer J Clin 68:64-89
Bandari, Shyam K; Purushothaman, Anurag; Ramani, Vishnu C et al. (2018) Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior. Matrix Biol 65:104-118
Gowda, Pramod S; Wildman, Benjamin J; Trotter, Timothy N et al. (2018) Runx2 Suppression by miR-342 and miR-363 Inhibits Multiple Myeloma Progression. Mol Cancer Res 16:1138-1148
Dix, Daniel B; McDonald, Andrew M; Gordetsky, Jennifer B et al. (2018) How Would MRI-targeted Prostate Biopsy Alter Radiation Therapy Approaches in Treating Prostate Cancer? Urology 122:139-146
Prince, Andrew C; Moore, Lindsay S; Tipirneni, Kiranya E et al. (2018) Evaluation of optical imaging agents in a fluorescence-guided surgical model of head and neck cancer. Surg Oncol 27:225-230
Gangrade, Abhishek; Pathak, Vibha; Augelli-Szafran, Corinne E et al. (2018) Preferential Inhibition of Wnt/?-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer. Int J Mol Sci 19:

Showing the most recent 10 out of 747 publications